Tuesday, April 23, 2024 4/23/2024

Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic Inflammation

Award Number: F31HL160178
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Harmful algal blooms (HABs) are on the rise globally and pose serious health concerns due to the release of cyanotoxins, which are harmful to both humans and the environment. Microcystin- LR (MC-LR) is one of the most frequently produced cyanotoxins and has recently been detected in aerosols generated by the normal motions of affected bodies of water. In the literature and our own preliminary data, it has been observed that MC-LR exposure of the airways leads to mixed granulocytic inflammation, with abundant indications of a Type 1 neutrophilic response. Granulocytic inflammation drives 4 of the 5 endotypes of asthma, which is the most common airway condition in the world and is associated with an increased risk of cardiovascular disease and stroke. However, the impact that MC-LR exposure may have on the over 330 million patients with pre-existing asthma remains unknown. Therefore, the overall hypothesis is that inhalation exposure to MC-LR worsens the symptoms of neutrophil-driven asthma by promoting granulocytic inflammation and stimulating effector immune mediators of airway inflammation. To address this hypothesis, Aim 1 is to expand on our preliminary studies by assessing the response to aerosol exposure by a 3-D human airway epithelium reconstructed in vitro from healthy and asthmatic donors. For Aim 2, we will assess key phenotypic characteristics such as lung function and immune infiltrates in a murine model of asthma after inhalation exposure to MC-LR aerosols. The information gathered in this study will inform communities around the world of the risks associated with exposure to aerosolized MC-LR, and how this environmental toxin may worsen disease in at-risk populations, potentially influencing local policies to protect people living on or around affected bodies of water. The pursuit of this project will provide excellent training opportunities in diverse models for exposure science, pulmonary science, and immunotoxicology. Specialized equipment available at the University of Toledo Health Science Campus will enable these novel studies. Furthermore, professionals from institutions including Wayne State University, University of Michigan and multiple Department of Energy National Laboratories will provide guidance and unique training in powerful techniques which will assure a strong independent research career in these fields of interest.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$1,167 )
2024	2022	UNIVERSITY OF TOLEDO	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	000	2	2/26/2024	NON-COMPETING CONTINUATION	-$1,167
														Subtotal = -$1,167

Issue Date FY: 2023 ( Subtotal = -$19,854 )
2023	2022	UNIVERSITY OF TOLEDO, THE	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	000	2	8/31/2023	NON-COMPETING CONTINUATION	-$19,854
														Subtotal = -$19,854

Issue Date FY: 2022 ( Subtotal = $40,448 )
2022	2022	UNIVERSITY OF TOLEDO, THE	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	001	2	8/9/2022	NON-COMPETING CONTINUATION	$40,448
2022	2021	UNIVERSITY OF TOLEDO, THE	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	000	1	3/1/2022	NEW	$0
														Subtotal = $40,448

Issue Date FY: 2021 ( Subtotal = $39,732 )
2021	2021	UNIVERSITY OF TOLEDO, THE	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	000	1	8/27/2021	NEW	$39,732
2021	2021	UNIVERSITY OF TOLEDO, THE	3000 ARLINGTON AVE	TOLEDO	OH	43614	LUCAS	USA	Lung Diseases Research	001	1	8/27/2021	NEW	$0
														Subtotal = $39,732

Grand Total All Awards = $59,159

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic Inflammation

Award Number: F31HL160178

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer